UnitedHealth Group Inc (UNH) Holdings Trimmed by Kistler Tiffany Companies LLC
Kistler Tiffany Companies LLC lowered its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,334 shares of the healthcare conglomerate’s stock after selling 48 shares during the period. Kistler Tiffany Companies LLC’s holdings in UnitedHealth Group were worth $582,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the business. Cognios Capital LLC raised its stake in shares of UnitedHealth Group by 14.1% in the 2nd quarter. Cognios Capital LLC now owns 4,873 shares of the healthcare conglomerate’s stock worth $1,195,000 after buying an additional 602 shares in the last quarter. FMR LLC raised its stake in shares of UnitedHealth Group by 5.1% in the 2nd quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock worth $15,118,428,000 after buying an additional 2,981,233 shares in the last quarter. Employees Retirement System of Texas raised its stake in shares of UnitedHealth Group by 0.6% in the 2nd quarter. Employees Retirement System of Texas now owns 292,600 shares of the healthcare conglomerate’s stock worth $71,786,000 after buying an additional 1,700 shares in the last quarter. Richard Bernstein Advisors LLC raised its stake in shares of UnitedHealth Group by 47.2% in the 2nd quarter. Richard Bernstein Advisors LLC now owns 2,938 shares of the healthcare conglomerate’s stock worth $721,000 after buying an additional 942 shares in the last quarter. Finally, Merriman Wealth Management LLC bought a new stake in shares of UnitedHealth Group in the 2nd quarter worth $372,000. 85.28% of the stock is currently owned by hedge funds and other institutional investors.
In other news, Director Kenneth Irwin Shine sold 163 shares of UnitedHealth Group stock in a transaction on Friday, November 9th. The stock was sold at an average price of $274.83, for a total transaction of $44,797.29. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Richard T. Burke sold 6,090 shares of UnitedHealth Group stock in a transaction on Wednesday, November 28th. The shares were sold at an average price of $281.72, for a total value of $1,715,674.80. Following the transaction, the director now owns 1,711,584 shares in the company, valued at approximately $482,187,444.48. The disclosure for this sale can be found here. 0.87% of the stock is owned by insiders.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.30 by $0.11. The company had revenue of $56.56 billion for the quarter, compared to analyst estimates of $56.34 billion. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. UnitedHealth Group’s revenue for the quarter was up 12.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.66 earnings per share. Analysts expect that UnitedHealth Group Inc will post 12.81 EPS for the current year.
UNH has been the topic of a number of research reports. Cowen initiated coverage on UnitedHealth Group in a research note on Monday, September 17th. They issued an “outperform” rating and a $308.00 price objective on the stock. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 18th. Raymond James boosted their price objective on UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a research note on Monday, September 24th. ValuEngine raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, October 2nd. Finally, Jefferies Financial Group boosted their price objective on UnitedHealth Group from $270.00 to $311.00 and gave the stock a “buy” rating in a research note on Wednesday, October 3rd. One analyst has rated the stock with a hold rating and twenty-three have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $293.86.
TRADEMARK VIOLATION WARNING: This piece was originally reported by Marea Informative and is owned by of Marea Informative. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://www.mareainformativa.com/news/2019/01/14/unitedhealth-group-inc-unh-holdings-trimmed-by-kistler-tiffany-companies-llc.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Book Value Per Share in Stock Trading
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.